HIF1A and neoplasm: The functionalized liposomes reduced the tumor by twofold more when compared with unmodified liposomes, suggesting the potential of gemcitabine/HIF1α-siRNA-loaded GE-11-modified liposomes in pancreatic cancer treatment [102].